Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation | Zendy

Brandon Webb | Zendy; Regan Healy | Zendy; Jacob Majers | Zendy; Zachary Burr | Zendy; Michaela A. Gazdik | Zendy; Bert K. Lopansri | Zendy; Daanish Hoda | Zendy; Finn Bo Petersen | Zendy; Clyde D. Ford | Zendy

Open Access

Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation

Author(s) -

Brandon Webb,

Regan Healy,

Jacob Majers,

Zachary Burr,

Michaela A. Gazdik,

Bert K. Lopansri,

Daanish Hoda,

Finn Bo Petersen,

Clyde D. Ford

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix232

Subject(s) - medicine , hematopoietic stem cell transplantation , enterococcus , vancomycin , hematopoietic cell , leukemia , transplantation , microbiology and biotechnology , haematopoiesis , immunology , stem cell , antibiotics , staphylococcus aureus , bacteria , biology , genetics

Bloodstream infection (BSI) to due vancomycin-resistant Enterococcus (VRE) is an important complication of hematologic malignancy. Determining when to use empiric anti-VRE antibiotic therapy in this population remains a clinical challenge.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research